Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin ETFs break 8-week outflow streak with $197M inflows, while Ethereum ETFs also see gains.

Market News
13 Jul 2026
AMBCrypto
View Source
Neutral
pluang ai news

U.S. spot Bitcoin ETFs ended an eight-week streak of outflows with $197 million in net inflows from July 6 to 10, led by BlackRock's IBIT. Despite fluctuations, Bitcoin's price remained volatile around $62,758.75. Ethereum spot ETFs also reversed outflows with $84.42 million inflows, while XRP ETFs saw outflows. This shift suggests renewed investor interest in crypto ETFs, though price movements remain uncertain in their impact on flows.

More News

AI use in cybersecurity jumps to 78% in 2026, but governance and failures lag behind.

AI use in cybersecurity jumps to 78% in 2026, but governance and failures lag behind.

The 2026 SANS AI Survey reveals rapid AI adoption in cybersecurity, with 78% of organizations using AI, up from 50% last year. However, governance structures and formal audit frameworks have not kept pace, leading to increased AI-related failures in ...

Market News
Neutral
1 hour ago
Head and neck squamous cell carcinoma market to grow 10.5% CAGR through 2036 with new immunotherapies.

Head and neck squamous cell carcinoma market to grow 10.5% CAGR through 2036 with new immunotherapies.

The head and neck squamous cell carcinoma (HNSCC) market is projected to grow at a 10.5% CAGR from 2026 to 2036, driven by rising cancer incidence and new immunotherapy launches. Key emerging therapies from companies like Johnson & Johnson, BioNTech,...

Market News
Bullish
3 hours ago
Noble Capital Markets starts coverage on VivoPower with Outperform rating and $10 target

Noble Capital Markets starts coverage on VivoPower with Outperform rating and $10 target

Noble Capital Markets has initiated equity research coverage on VivoPower PLC, assigning an Outperform rating and setting a price target of $10. VivoPower is a B Corp-certified global developer of powered land and data center infrastructure for AI ap...

Analyst Insights
Bullish
3 hours ago
Alamar Biosciences launches national study using blood tests to advance Alzheimer's biomarker research.

Alamar Biosciences launches national study using blood tests to advance Alzheimer's biomarker research.

Alamar Biosciences has partnered with leading U.S. universities to launch a nationwide proteomics study analyzing around 21,000 plasma samples from 10,000 Alzheimer's and related dementia patients. Using its NULISAseq™ Neuro 220 test kit, the project...

Market News
Bullish
3 hours ago
Alamar Biosciences launches national study analyzing 21,000 plasma samples to advance Alzheimer's biomarkers.

Alamar Biosciences launches national study analyzing 21,000 plasma samples to advance Alzheimer's biomarkers.

Alamar Biosciences has partnered with top U.S. research universities to start a nationwide proteomics project using its NULISAseq™ Neuro 220 panel. The study will analyze about 21,000 plasma samples from 10,000 Alzheimer's and related dementia partic...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App